Linguistic validation of the inflammatory bowel disease questionnaire-short form (IBDQ-9) in Iranian population

Journal of Isfahan Medical School

Volumn 28, Issue 123, 2011, Pages

  Gholamrezaei, Ali ^a   Haghdani, Saeid ^a   Shemshaki, Hamidreza ^a   Tavakoli, Hamid ^a   Emami, Mohammad Hassan ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Inflammatory bowel disease; Linguistic validation; Quality of life; Reliability; Validity

Indexed keywords

ANXIETY; ARTICLE; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; CRONBACH ALPHA COEFFICIENT; DEPRESSION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE 9; INTERNAL CONSISTENCY; LANGUAGE; MAJOR CLINICAL STUDY; QUESTIONNAIRE; SIMPLE CLINICAL COLITIS ACTIVITY INDEX; ULCERATIVE COLITIS; VALIDATION PROCESS;

EID: 84936938796     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347(6): 417-29.
2. Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 2005; 20(11): 1691-5.
3. Pizzi LT, Weston CM, Goldfarb NI, Moretti D, Cobb N, Howell JB, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12(1): 47-52.
4. Irvine EJ. Is disease-specific health-related quality of life measurement a necessary evil when assessing clinical outcomes in inflammatory bowel disease? Dig Liver Dis 2000; 32(8): 689-90.
5. Fayers PM, Machin D. Quality of Life: The assessment, analysis and interpretation of patientreported outcomes. 2nd ed. New York: John Wiley & Sons; 2007.
6. Hodgson HJF, Bhatti M. Assessment of disease activity in ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1995; 1(2):117-34.
7. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF- 36): Translation and validation study of the Iranian version. Quality of Life Research 2005; 14: 875-82.
8. Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994; 106(2): 287-96.
9. Verissimo R. Quality of life in inflammatory bowel disease: psychometric evaluation of an IBDQ cross-culturally adapted version. J Gastrointestin Liver Dis 2008; 17(4): 439-44.
10. Irvine EJ. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. 1996.
11. Casellas F, Alcala MJ, Prieto L, Miro JR, Malagelada JR. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am J Gastroenterol 2004; 99(3): 457-61.
12. Elliott PR, Lennard-Jones JE, Hathway N. Simple index of Crohn's disease activity. Lancet 1980; 1(8173): 876.
13. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998; 43(1): 29-32.
14. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005; 8(2): 94-104.
15. Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006; 130(5): 1538-51.
16. Bijkerk CJ. Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. 2003.